Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Depreciation & Amortization (CF) (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Depreciation & Amortization (CF) for 8 consecutive years, with $350000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 51.05% to $350000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $1.6 million, a 62.71% decrease, with the full-year FY2024 number at $3.4 million, down 50.07% from a year prior.
  • Depreciation & Amortization (CF) was $350000.0 for Q3 2025 at Precision Biosciences, down from $378000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $2.4 million in Q2 2021 to a low of $350000.0 in Q3 2025.
  • A 5-year average of $1.5 million and a median of $1.9 million in 2022 define the central range for Depreciation & Amortization (CF).
  • Peak YoY movement for Depreciation & Amortization (CF): rose 7.4% in 2021, then plummeted 65.44% in 2025.
  • Precision Biosciences' Depreciation & Amortization (CF) stood at $2.2 million in 2021, then decreased by 9.89% to $2.0 million in 2022, then crashed by 34.74% to $1.3 million in 2023, then crashed by 64.5% to $454000.0 in 2024, then decreased by 22.91% to $350000.0 in 2025.
  • Per Business Quant, the three most recent readings for DTIL's Depreciation & Amortization (CF) are $350000.0 (Q3 2025), $378000.0 (Q2 2025), and $395000.0 (Q1 2025).